Browsing Tag

ALS Drug

FDA panel backs much-debated ALS drug in rare, 2nd review

Jason Junior Sep 8, 2022

By MATTHEW PERRONE - AP Health Writer WASHINGTON (AP) — A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig’s disease, a remarkable…

Health

FDA still skeptical of ALS drug ahead of high-stakes meeting

Jason Junior Sep 3, 2022

By MATTHEW PERRONE - AP Health Writer WASHINGTON (AP) — Federal health regulators remain unconvinced about the benefits of a closely watched experimental drug for the debilitating illness known as Lou…

Health

FDA skeptical of benefits from experimental ALS drug

Jason Junior Mar 29, 2022

WASHINGTON (AP) — Federal health regulators issued a negative review Monday of a closely watched…

Health

FDA reviews ALS drug after lobbying by patients, politicians

Jason Junior Mar 24, 2022

WASHINGTON (AP) — When patients are battling a terminal illness and want access to an experimental drug, how…

Health

Repurposed ALS Drug Against Rare Genetic Disorder

Jason Junior Nov 21, 2021

Riluzole, a repurposed ALS (amyotrophic lateral sclerosis) drug may help slow down a rare genetic disorder called Niemann-Pick disease type C1 (NPC1 - characterized by the gradual loss of a particular brain cell) in children and…